Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy

Autor: Luca Scafuri, Carlo Buonerba, Vincenzo Di Lauro, Vincenzo Tortora, Marco Cascella, Luigi Liguori, Antonella Sciarra, Francesco Sabbatino, Anna Diana, Antonio Marra, Paolo Tarantino, Dario Trapani, Mario Giuliano, Grazia Arpino, Giuseppe Curigliano, Giuseppe Di Lorenzo

Publikováno v: Oncology and Therapy, Vol 12, Iss 3, Pp 363-373 (2024)

Abstract Background Breast cancer presents diverse molecular subtypes affecting treatment strategies. Human epidermal growth factor receptor 2 (HER2)-low, hormone receptor-positive (HR+) breast cancer poses a challenge due to limited targeted therapi

Externí odkaz: https://doaj.org/article/2b162889839543f080aaba98a06a8db9

Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients

Autor: Francesco Sabbatino, Valeria Conti, Luigi Liguori, Giovanna Polcaro, Graziamaria Corbi, Valentina Manzo, Vincenzo Tortora, Chiara Carlomagno, Carmine Vecchione, Amelia Filippelli, Stefano Pepe

Publikováno v: Life, Vol 11, Iss 2, p 105 (2021)

Reactive oxygen species (ROS) are molecules involved in signal transduction pathways with both beneficial and detrimental effects on human cells. ROS are generated by many cellular processes including mitochondrial respiration, metabolism and enzymat

Externí odkaz: https://doaj.org/article/559465818bcf46ec95c313c06bc7bf18

Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients

Autor: Chiara Carlomagno, Vincenzo Tortora, Amelia Filippelli, Luigi Liguori, Carmine Vecchione, Francesco Sabbatino, Valeria Conti, Graziamaria Corbi, Valentina Manzo, Stefano Pepe, Giovanna Polcaro

Publikováno v: Life, Vol 11, Iss 105, p 105 (2021)
Life

Reactive oxygen species (ROS) are molecules involved in signal transduction pathways with both beneficial and detrimental effects on human cells. ROS are generated by many cellular processes including mitochondrial respiration, metabolism and enzymat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06fe042d7de5217e1e6c84950ef8dd1
http://hdl.handle.net/11695/98430

The influence of prednisone on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer

Autor: Brigitta Mucci, Livio Puglia, Sabino De Placido, Guru Sonpavde, Francesca Foschini, Carlo Buonerba, Simona Iaccarino, Ileana Di Costanzo, Giuseppe Di Lorenzo, Francesca Vitrone, Vincenzo Tortora, Vittorio Riccio, Luca Scafuri, Margherita Muratore, Dario Ribera, Davide Bosso, Mirta Mosca, Martina Pagliuca, Nicola Cesarano, Michela Izzo, Rocco Morra

Publikováno v: Journal of Cancer

Background: Cabazitaxel is a second-generation taxane that is approved for use with concomitant low dose daily prednisone in metastatic castration resistant prostate cancer (mCRPC) after docetaxel failure. Since the role of daily corticosteroids in i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1bf287bdf1551393db0df7f27ce1add
http://hdl.handle.net/11588/789593

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists

Autor: Sara Parola, Diletta Cavallero, Pietro De Placido, Rossella Di Franco, Francesca Zacchi, Giacomo Cartenì, Sabino De Placido, Claudia von Arx, Alice Rossi, Fernanda Picozzi, Pasquale Rescigno, Laura Attademo, Giovannella Palmieri, Carminia Maria Della Corte, Fabiana Vitiello, Anna Russo, Lucia Nappi, Michele Aieta, Alessia Mennitto, Fabiana Napolitano, Marco Messina, Giuseppe Buono, Valeria Merz, Marco De Felice, Stefano De Falco, Immacolata Paciolla, Irene De Santo, Dario Trapani, Antonio M. Grimaldi, Paolo Tarantino, Alessandro Morabito, Tortora Vincenzo, Stefano Pepe, Giuseppe Palmieri, Antonietta Fabbrocini, Diana Giannarelli, Alfonso De Stefano, Sabrina Vari, Cesare Gridelli, Vittorio Riccio, Angelica Petrillo, Martina Pagliuca, Giuseppe Calderoni, Margaret Ottaviano, Vincenza Conteduca, Michela Lia, Giuseppe Santabarbara, Ester Simeone, Valentina Borzillo, Francesca Caputo, Mario Rosanova, Marcello Curvietto, Pasquale Assalone, Brigitta Mucci, Raffaele Conca, Vito Vanella, Francovito Piantedosi, Vincenzo Montesarchio, Erica Pietroluongo, Lucia Festino, Federica Tomei, Vincenzo Di Lauro, Bruno Daniele, Caterina Vivaldi, Andrea Zivi, Veronica Prati, Pasqualina Giordano, Luisa Piccin, Francesco Bloise, Massimiliano Spada, Jole Ventriglia, Davide Bosso, Alessandro Marco Minisini, Massimiliano Salati, Monica Milano, Carlo Messina, Valentina Massa, Mario Giuliano, Claudia Trojanello, Antonella Lucia Marretta, Fortunato Ciardiello, Antonio Avallone, Marianna Tortora, Ilaria Zampiva, Alessia Cavo, Floriana Morgillo, Andrea Sbrana, Piera Federico, Maria Grazia Vitale, Sandro Pignata, Antonia Silvestri, Paola Taveggia, Sara Merler, Paolo A. Ascierto, Michelino De Laurentiis

Publikováno v: Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has overwhelmed the health systems worldwide. Data regarding the impact of COVID-19 on cancer patients (CPs) undergoing or candidate for immune checkpoint inhibitors (ICIs) are lacking. We de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bbec51cbd465b3f335830ebbeec5bef
http://hdl.handle.net/11568/1114478